Abstract
Germline mutations in genes encoding several components of the retinoblastoma pathway have been linked with inherited predisposition to melanoma. Most commonly, such mutations involve CDKN2A, a cyclin-dependant kinase inhibitor of two kinases, CDK4 and CDK6, which phosphorylate the retinoblastoma protein (pRB) and thereby promote passage through the G1/S cell-cycle restriction point. Less frequently, germline mutations in the CDK4 gene have also been linked with an increased risk of melanoma. Despite the sequence and functional homology between CDK4 and CDK6, the role of germline mutations in CDK6 in melanoma predisposition is unknown. We detected no CDK6 mutations within the p16 (CDKN2A) binding domain in index cases from 60 melanoma-prone kindreds that lacked germline mutations in the coding regions of either CDKN2A or within the entire CDK4 coding region. We conclude that germline mutations in CDK6 do not make a significant contribution to melanoma predisposition.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bataille V, Hiles R and Bishop JA . 1995 Br J Dermatol 132: 134–138
Brotherton DH, Dhanaraj V, Wick S, Brizuela L, Domaille PJ, Volyanik E, Xu X, Parisini E, Smith BO, Archer SJ, Serrano M, Brenner SL, Blundell TL and Laue ED . 1998 Nature 395: 244–250
Byeon I-JL, Li J, Ericson K, Selby TL, Tevelev A, Kim H-J, O'Maille P and Tsai M-D . 1998 Mol Cell Biol 18: 421–431
Ceha HM, Nasser I, Medema RH and Slebos RJC . 1998 Biochem Biophys Res Commun 249: 550–555
Coleman KG, Wautlet BS, Morrisseys D, Mulheron J, Sedman SA, Brinkley P, Price S and Webster KR . 1997 J Biol Chem 272: 18869–18874
Dracopoli NC and Fountain JW . 1996 Cancer Surv 26: 115–132
Draper GJ, Sanders BM and Kingston JE . 1986 Br J Cancer 53: 661–671
Eng C, Li FP, Abramson DH, Ellsworth RM, Wong FL, Goldman MB, Seddon J, Tarbell N and Boice Jr JD . 1993 J Natl Cancer Inst 85: 1121–1128
FitzGerald MG, Harkin DP, Silva-Arieta S, MacDonald DJ, Lucchina LC, Unsal H, Koh J, Finkelstein DM, Isselbacher KJ, Sober AJ and Haber DA . 1996 Proc Natl Acad Sci USA 93: 8541–8545
Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark Jr WH, Tucker MA and Dracopoli NC . 1994 Nature Genet 8: 15–21
Kato J, Matsushime H, Hiebert S, Ewen ME and Sherr CJ . 1993 Genes Dev 7: 331–342
Liu L, Lassam NJ, Slingerland JM, Bailey D, Jenkins R and Hogg D . 1995 Oncogene 11: 405–412
Liu L, Dilworth D, Gao L, Monzon J, Summers A, Lassam N and Hogg D . 1999 Nature Genet 21: 128–132
Luh FY, Archer SJ, Domaille PJ, Smith BO, Owen D, Brotherton DH, Raine ARC, Xu X, Brizuela L, Brenner SL and Laue ED . 1997 Nature 389: 999–1003
Miller SA, Dykes DD and Polesky HF . 1988 Nucleic Acids Res 16: 1215
Ruas M and Peters G . 1998 Biochem Biophys Acta 1378: F115–F177
Russo AA, Tong L, Lee J-O, Jeffrey PD and Pavletich NP . 1998 Nature 395: 237–243
Serrano M, Hannon GJ and Beach D . 1993 Nature 366: 704–707
Soufir N, Avril MF, Chompret A, Demenais F, Bombled J, Spatz A, Stoppa-Lyonnet D, the French Familial Melanoma Study Group, Benard J and Bressac-de Paillerets B . 1998 Hum Mol Gen 7: 209–216
Traboulsi EI, Zimmerman LE and Manz HJ . 1988 Arch Ophthamol 106: 1059–1061
Tucker MA and Goldstein AM . 1995 Dermatol Clin 13: 605–612
Walker GJ, Hussussian CJ, Flores JF, Glendening JM, Haluska FG, Dracopoli NC, Hayward NK and Fountain JW . 1995 Hum Mol Genet 4: 1845–1852
Weinberg RA . 1995 Cell 8: 323–329
Zuo L, Weger J, Yang Q, Goldstein AM, Tucker MA, Walker GJ, Hayward N and Dracopoli NC . 1996 Nature Genet 12: 97–99
Acknowledgements
This work was supported by grants from the National Cancer Institute of Canada.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shennan, M., Badin, AC., Walsh, S. et al. Lack of germline CDK6 mutations in familial melanoma. Oncogene 19, 1849–1852 (2000). https://doi.org/10.1038/sj.onc.1203507
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203507
Keywords
This article is cited by
-
Cytoplasmic and nuclear expression of survivin in melanocytic skin lesions
Archives of Dermatological Research (2005)
-
Germline splicing mutations of CDKN2A predispose to melanoma
Oncogene (2003)